Education
About Us
Working with TipRanks
Follow Us
Edward Miller Insider Profile
4 Followers
Edward Miller, SVP & CCO at Alexion Pharmaceuticals, holds 21.57K shares in Kalaris Therapeutics (Ticker: KLRS), holds 14.21K shares in Alexion Pharmaceuticals (Ticker: ALXN). Most recently, Edward Miller Sold ― shares of Kalaris Therapeutics on Feb 24, 2025 for an estimated value of 1.07K.
Profitable Transactions
25 out of 26 Profitable Transactions
Average Return
+57.10%
Average return per transaction
Time Frame
Compare to
Insider Roles
GC
Roles that Edward Miller holds in companies
Most Profitable Insider Trade
The most profitable trade made by Edward Miller
Edward Miller's Trading History
Alexion Pharmaceuticals
Mar 01, 2017
―
Uninformative Buy
―
$2.59M
Kalaris Therapeutics
Feb 24, 2025
GC
Informative Sell
1.07K
$61.27K
List of latest transactions for each holding click on a transaction to see Edward Miller's performance on stock
You May Also Like
Edward Miller insider profile FAQ
What is the percentage of profitable transactions made by Edward Miller?
The percentage of profitable transactions made by Edward Miller is 96%.
What is the average return per transaction made by Edward Miller?
The average return per transaction made by Edward Miller is 57.10%.
What stocks does Edward Miller hold?
Edward Miller holds: ALXN, KLRS stocks.
What was Edward Miller’s latest transaction?
Edward Miller latest transaction was an Informative Sell of $1.07K.
What was Edward Miller's most profitable transaction?
Edward Miller’s most profitable transaction was an Informative Sell of KLRS stock on November 6, 2024. The return on the trade was 89.70%.
What is Edward Miller's role in Alexion Pharmaceuticals?
Edward Miller's role in Alexion Pharmaceuticals is SVP & CCO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.